SYNCOM FORMULATIONS (INDIA)
Back to Balance Sheet
|
SYNCOM FORMULATIONS (INDIA) Last 5 Year Total Debt History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2017 | |
|---|---|---|---|---|---|
| Total Debt | ₹4.58 Cr | ₹72 Cr | ₹83 Cr | ₹58 Cr | ₹12 Cr |
What is the latest Total Debt ratio of SYNCOM FORMULATIONS (INDIA) ?
| Year | Total Debt |
|---|---|
| Mar2025 | ₹4.58 Cr |
| Mar2024 | ₹72 Cr |
| Mar2023 | ₹83 Cr |
| Mar2022 | ₹58 Cr |
| Mar2017 | ₹12 Cr |
How is Total Debt of SYNCOM FORMULATIONS (INDIA) Trending?
| Years | Total Debt | % Change | |
|---|---|---|---|
| Mar2025 | ₹4.58 Cr | -93.68 | |
| Mar2024 | ₹72 Cr | -12.86 | |
| Mar2023 | ₹83 Cr | 43.94 | |
| Mar2022 | ₹58 Cr | 364.15 | |
| Mar2017 | ₹12 Cr | - | |
Compare Total Debt of peers of SYNCOM FORMULATIONS (INDIA)
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SYNCOM FORMULATIONS (INDIA) | ₹1,343.3 Cr | 1% | 3.9% | -33.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹433,620.0 Cr | 1% | -0.9% | 6.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹176,087.0 Cr | 1.8% | -2.3% | 1.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹154,837.0 Cr | 3.7% | 6.5% | 44.9% | Stock Analytics | |
| CIPLA | ₹112,194.0 Cr | 0% | 4.7% | -8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,328.0 Cr | -0.2% | 0.7% | -3.4% | Stock Analytics | |
SYNCOM FORMULATIONS (INDIA) Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SYNCOM FORMULATIONS (INDIA) | 1% |
3.9% |
-33.1% |
| SENSEX | 1.7% |
1.3% |
-7.3% |
You may also like the below Video Courses